Current Aspects of Antibiotic Therapy of Community-Acquired Pneumonia in Children of Early and Preschool Age (Review)
DOI:
https://doi.org/10.22141/2224-0551.3.71.2016.76349Keywords:
children, community-acquired pneumonia, empirical antibiotic therapyAbstract
In this article we analyzed current antibiotic resistance of S.pneumoniae. We showed local (region) data on sensitivity of pneumococcus to aminopenicillins, macrolides and cephalosporines traditionally used in schemes of empirical antibiotic therapy of community-acquired pneumonia in children under 5 years. We laid basic principles of rational antibiotic therapy based on the analysis of current national and foreign guidelines on the treatment of community-acquired pneumonia. Insignificant differences in the schemes of empirical antibiotic therapy are marked due to peculiarities of local resistance of S.pneumoniae in different countries. We discussed propriety of some positions of empirical antibiotic therapy in children of early and preschool age.Downloads
References
Abaturov AE, Gerasimenko ON. Features of the antibacterial therapy of respiratory infections in children. Zdorov`e rebenka. 2014;5(56):61-65. Russian
Veselov AV. Amoxicillin/clavulanate: features of pharmacokynetics and pharmacoeconomics in the treatment of respiratory infections. Gazeta “Novosti mediciny I farmacii” Allergologiya, pul’monologiya. 2009:295. Russian
Community-acquired pneumonia in children: occurrence, diagnostics, treatment and prophylactics. Nauchno-prakticheskaya programma; М: 2011 63 p. Russian
WHO, newsletter. [Internet]. [cited 2012 Nov];331. Available from: http://www.who.int/medcentre/factsheets/fs331/ru/index.html. Russian
Vysochina IL, Krivusha EL, Rusakova EA. Community-acquired pneumonia in children. Zdorov'e rebenka. 2014;2(53):101-105. Russian
Geppe NA, Snegockaya MN, Evdokimov EM. Community-acquired pneumonia. Diagnostics and treatment. Praktika pediatra. 2005;10. Russian
Kozlov RS, Sivaya OV, Krechikova OI, Ivanchik NV. Dynamics of the resistance of Streptococcus pneumoniae to antibiotics in Russia in 1999-2009years. Results of multicenter prospective study PeGAS. Klin mikrobiol antimikrob himioter. 2010;12(4):329-341. Russian
Lazareva MA, Kulichenko TV, Alyab'eva NM i dr. Nasopharyngeal carriage of Streptococcus pneumoniae in children from orphanages, preschools and disorganized children under 5 years. Voprosy sovremennoj pediatrii. 2015;14(2):246-255. Russian
Majdannik VG. Community-acquired pneumonia n children. Using of azithromycin according to evidence-based medicine. Mezhdunarodnyj zhurnal pediatrii, akusherstva i ginekologii. 2012;2(1):95-111. Russian
Majdannik VG, Emchins'ka EO. Clinical guidelines of diagnostics and treatment of community-acquired pneumonia in children. К; 2013. 32 p.. Ukrainian
Majdannik VG. Clarithromycin in the treatment of low respiratory tract diseases in children. Mezhdunarodnyj zhurnal pediatrii, akusherstva i ginekologii. 2015;2:64-75. Russian
Makarova MA. Features of intensive care of necrotizing pneumonia in children. ScienceRise. 2015;7(4):78-82. Russian
Chernishova LI, Gіl'fanova AM, Bondarenko AV, ta in. Multiple antibiotic resistence of Streprococcus pneumoniae. Empirical antibacterial therapy of pneumococcal infection in children. Sovremennaya pediatriya. 2015;5:49-54. Ukrainian
Mostovoj YuM, Demchuk AV. Macrolides and allergy. Astma ta alergіya. 2015;2:53-60. Ukranian
Berezhnoj VV, Orlyuk YB, Kozachuk VG, i dr. Experience of using Flemoxin solutab in outpatient treatment of children with infections of upper and low respiratory tract. Zdorov`e Ukray`ny [Internet]. 2003;70. Available from: http://www.health-ua.org/archives/health/182.html Russian
Strachunskij LS, Belousov YuB, Kozlov SN i dr. The practical guideline on antiinfection chemotherapy. Smolensk: MAKMAH; 2007. 464 p. Russian
Volosovets AP, Abaturov AE, Besh LV i dr. Results of multicenter study “Ceph-PROSTO” (cephpodoxima proxetil in the initial therapy of community-acquired pneumonia in children)in Ukraine. Sovremennaya pediatriya. 2011;2(36):107-112. Russian
Tatochenko VK. Flemoxin Solutab – optimal form of amoxicillin. Detskij doktor. 2001;1:42-44. Russian
Shihnebiev DA. Current antibacterial therapy of community-acuired pneumonia (review). Mezhdunarodnyj zhurnal prikladnyh i fundamental'nyh issledovanij. 2014;4:101-104. Russian
Levina AS, Babachenko IV, Sharipova EV I dr. Etiological agerelated description of community-acquired pneumonia in children. Pul’monologiya. 2014;5:62-66. Russian
Pikuza OI, Zakirova AM, Samorodnova EA, i dr. Efficacy of amoxicillin/clavulanate in care of acute community-acquired pneumonia in children. PF. 2006;5:60-62. Russian
Yulish EI, Balychevceva IV, Gadeckaya SG. Dispersible dosage form of amoxicillin in treatment of not severe community-aqcuired pneumoniain children. Zdorov'e rebenka. 2013;2:59-62. Russian
Yulish EI, Pantofel'man OYu. Macrolides in treatment of respiratory tract diseases in children caused by extracellular and cellular organisms. Zdorov'e rebenka. 2014;4:63-67. Russian
Ball P, Baquero F, Cars O et al. Consensus Group on Resistance and Prescribing in Respiratory Tract Infection. Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence. Journal of Antimicrobial Chemotherapy. 2002;49(1):31-40. PMID:11751764
Asada M, Yoshida M, Suzuki T, Hatachi Y, Sasaki T, Yasuda H, Nakayama K, Nishimura H, Nagatomi R, Kubo H, Yamaya M. Macrolide antibiotics inhibit respiratory syncytial virus infection in human airway epithelial cells. Antiviral Research. 2009;83(2):191-200. doi: 10.1016/j.antiviral.2009.05.003
Dagan R, Johnson C, McLinn S, Abughali N, Feris J, Leibovitz E, Burch D, Jacobs M. Bacteriologic and clinical efficacy of amoxicillin/clavulanate vs. azithromycin in acute otitis media. The Pediatric Infectious Disease Journal. 2000;19(2):95-104. PMID:10693993
Harris M, Clark N, Fletcher P, Harnden A, Mckean M, Thomson A. British Thoracic Society guidelines for the management of community-acquired pneumonia in children: update 2011. Thorax. 2011;66(Suppl 2):ii1-ii23. doi: 10.1136/thoraxjnl-2011-200598.
Comte R, Pechere J, Kohler T, Yamaguchi K, Van Delden C. Azithromycin Inhibits Quorum Sensing in Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 2001;45(6):1930-1933. doi: 10.1128/AAC.45.6.1930-1933.2001
Feshchenko Y, Dzyublik F, Pertseva T, et al. Antibacterial resistance among Streptococcus pneumonia and Haemophilus influenza from Ukraine: Results from the Survey of Antibiotic Resistance (SOAR) 2011—2013. Poster presentation (P-1589). 24th ECCMID. 2014. Barselona, Spain. PMid:25823339
Franquet T. Imaging of pneumonia: trends and algorithms. European Respiratory Journal. 2001;18(1):196-208. PMID:11510793
Gielen V, Johnston S, Edwards M. Azithromycin induces anti-viral responses in bronchial epithelial cells. European Respiratory Journal. 2010;36(3):646-654. doi: 10.1183/09031936.00095809
Dwyer L, Harris-Kojetin L, Valverde R, Frazier J, Simon A, Stone N, Thompson N. Infections in Long-Term Care Populations in the United States. Journal of the American Geriatrics Society. 2013;61(3):342-349. PMID:23496650
Long S. Variability in care for children hospitalized for pneumonia: no excuses this time. The Journal of Pediatrics. 2014;165(3):427-429. doi:10.1016/j.jpeds.2014.07.015
Menendez R, Torres A, Zalacaín R Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome. Thorax. 2004;59(11):960-965. doi:10.1136/thx.2003.017756
Swami S, Banerjee R. Comparison of hospital-wide and age and location - stratified antibiograms of S. aureus, E. coli, and S. pneumoniae: age- and location-stratified antibiograms. SpringerPlus. 2013;2(1):63. Available:http://www.springerplus.com/content/2/1/63. doi: 10.1186/2193-1801-2-63
Shimizu T, Suzaki H. Past, present and future of macrolide therapy for chronic rhinosinusitis in Japan. Auris Nasus Larynx. 2015; Available: http://dx.doi.org/10.1016/j.anl.2015.08.014.
Brown S., Farrell D. Antibacterial susceptibility among Streptococcus pneumoniae isolated from paediatric and adult patients as part of the PROTEKT US study in 2001-2002. Journal of Antimicrobial Chemotherapy. 2004;54(suppl_1):23-29. doi: 10.1093/jac/dkh311
Lassi Z, Das J, Haider S, Salam R, Qazi S, Bhutta Z. Systematic review on antibiotic therapy for pneumonia in children between 2 and 59 months of age. Archives of Disease in Childhood. 2014;99(7):687-693.
Bradley J, Byington C, Shah S, Alverson B, Carter E, Harrison C, Kaplan S, Mace S, McCracken G, Moore M, St Peter S, Stockwell J, Swanson J. The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clinical Infectious Diseases. 2011;53(7):25-76. doi: 10.1093/cid/cir531
Washington L, Palacio D. Imaging of Bacterial Pulmonary Infection in the Immunocompetent Patient. Seminars in Roentgenology. 2007;42(2):122-145. PMID:1739492
Vanhoof R, Camps K, Carpentier M, De Craeye S, Frans J, Glupczynski Y, Goffinet P, Gordts B, Govaerts D, Ide L, Lefèvre P, Lontie M, Cartuyvels R, Meunier F, Mulongo B, Philippart I, Surmont I, Van Bossuyt E, Van Eldere J, Verhaegen J. 10th Survey of antimicrobial resistance in noninvasive clinical isolates of Streptococcus pneumoniae collected in Belgium during winter 2007–2008. Pathologie Biologie. 2010;58(2):147-151. doi: 10.1016/j.patbio.2009.07.018
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2016 S.A. Mokiya-Serbina, T.V. Litviniva, A.A. Gordyeyeva
This work is licensed under a Creative Commons Attribution 4.0 International License.